Catabasis Pharmaceuticals, Inc.

Release Summary

Catabasis Pharmaceuticals (NASDAQ:CATB) announced that it will present data from Part B of the MoveDMD trial at the 2017 Muscular Dystrophy Association Scientific Conference.

Catabasis Pharmaceuticals, Inc.